Influenza vaccination of human immunodeficiency virus (HIV)-infected adults: Impact on plasma levels of HIV type 1 RNA and determinants of antibody response

Clinical Infectious Diseases

Volumn 28, Issue 3, 1999, Pages 541-547

  Fuller, Jon D ^a,b,c,d   Craven, Donald E ^a,b,c   Steger, Kathleen A ^a,b,c   Cox, Nancy ^a,b,c   Heeren, Timothy C ^a,b,c   Chernoff, David ^a,b,c  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c NOVARTIS PHARMA AG   (Switzerland)

^d BOSTON MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; VIRUS RNA;

ADULT; AGE; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; CLINICAL ARTICLE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE RESPONSE; INFECTION PREVENTION; INFLUENZA; INFLUENZA VACCINATION; LYMPHOCYTE COUNT; MALE; PRIORITY JOURNAL; VIRUS DETECTION; VIRUS LOAD;

EID: 0032973536     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/515170     Document Type: Article

References (35)

1. 1. Stanley SK, Ostrowski MA, Justement JS, et al. Effect of immunization with a common recall antigen on viral expression in patients infected with human immunodeficiency virus type 1. N Engl J Med 1996;334: 1222-30.
2. 2. Brichacek B, Swindells S, Janoff EN, Pirruccello S, Stevenson M. Increased plasma human immunodeficiency virus type 1 burden following antigenic challenge with pneumococcal vaccine. J Infect Dis 1996;174: 1191-9.
3. 3. Ho DD. HIV-1 viraemia and influenza. Lancet 1992;339:1549.
4. 4. Markowitz NP, Baxa DM, Bush CE, Huitsing J, Baxa A, Donovan RM. The effect of influenza vaccination on HIV RNA load [abstract I-49]. In: Program and abstracts of the 37th Interscience Congress on Antimicrobial Agents and Chemotherapy (Toronto). Washington, DC: American Society for Microbiology, 1997.
5. 5. O'Brien WA, Ovcak S, Kalhor H, Mao SH, Zack JA. HIV-1 replication can be increased in blood from seropositive patients following influenza immunization [abstract PO-A12-0209]. In: Program and abstracts of the 9th International AIDS Conference (Berlin). Berlin: Institute for Clinical and Experimental Virology of the Free University of Berlin, 1993.
6. 6. Staprans SI, Hamilton BL, Follansbee SE, et al. Activation of virus replication after vaccination of HIV-1-infected individuals. J Exp Med 1995; 182:1727-37.
7. 7. Tasker S, O'Brien W, Rossetti R, et al. Effects of influenza vaccination in HIV infected patients: a double-blinded, placebo-controlled trial [abstract LB-11]. In: Program and abstracts of the 35th Interscience Congress on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
8. 8. Ward C, Salvato P, Thompson C. HIV RNA changes in HIV-positive patients following influenza vaccination [abstract We.B. 114]. In: Program and abstracts of the XI International Conference on AIDS (Vancouver, British Columbia, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
9. 9. Rosok B, Voltersvik P, Bjerknes R, Axelsson M, Haaheim LR, Asjo B. Dynamics of HIV-1 replication following influenza vaccination of HIV + individuals. Clin Exp Immunol 1996;104:203-7.
10. 10. O'Brien WA, Grovit-Ferbas K, Namazi A, et al. Human immunodeficiency virus-type 1 replication can be increased in peripheral blood of seropositive patients after influenza vaccination. Blood 1995;86:1082-9.
11. 11. Greenblatt R, Wieder E, Karliner L, et al. HIV-1 RNA levels and expression of immune activation markers among adults during common acute infections and convalescence [abstract no 116]. In: Program and abstracts of the 4th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: IDSA for Foundation for Retrovirology and Human Health, 1997.
12. 12. Nelson RP Jr, Robert P, Ledford D, et al. Quantitative RNA levels before and after influenza immunizations in HIV-infected adults [abstract WeB113]. In: Program and abstracts of the XI International Conference on AIDS (Vancouver, British Columbia, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
13. 13. Fowke KR, D'Amico R, Chernoff DN, et al. Immunologic and virologic evaluation after influenza vaccination of HIV-1-infected patients. AIDS 1997;11:1013-21.
14. 14. Glesby MJ, Hoover DR, Farzadegan H, Margolick JB, Saah AJ. The effect of influenza vaccination on human immunodeficiency virus type I load: a randomized, double-blind, placebo-controlled study. J Infect Dis 1996; 174:1332-6.
15. 15. Nelson KE, Clements ML, Miotti P, Cohn S, Polk BF. The influence of human immunodeficiency virus (HIV) infection on antibody responses to influenza vaccines. Ann Intern Med 1988;109:383-8.
16. 16. Reboli AC, Lukac SM, Baxter JD, Chernoff D, Hayden FG. The serologic response and late effects on viral load and CD4 count of influenza vaccination in HIV-infected patients with CD4 counts ≥200 [abstract 516]. Clin Infect Dis 1997;25:450.
17. 17. Yerly S, Wunderli W, Wyler CA, et al. Influenza immunization of HIV-1-infected patients does not increase HIV-1 viral load. AIDS 1994;8: 1503-4.
18. 18. Jackson CR, Vavro CL, Valentine ME, et al. Effect of influenza immunization on immunologic and virologic characteristics of pediatric patients infected with human immunodeficiency virus 1. Pediatr Infect Dis J 1997;16:200-4.
19. 19. Cutillar-Garcia M, Deveikis A, Gagajena A, et al. Pneumococcal and influenza immunization and HIV viral load in children [abstract 255]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Foundation for Retrovirology and Human Health, 1998.
20. 20. Krantz V, Rey D, Libbrecht E, et al. Hepatitis B vaccination response to 6 vs. 3 immunizations in HIV-infected patients, and effects on HIV-1 viral load [abstract 497]. In: Program and abstracts of the 5th Conference on Retroviruses and Opportunistic Infections (Washington, DC). Alexandria, VA: Foundation for Retrovirology and Human Health, 1998.
21. 21. Donovan RM, Moore E, Bush CE, Markowitz NP, Saravolatz LD. Changes in plasma HIV RNA levels and CD4 cell counts after vaccination of pediatric patients. AIDS 1997;11:1054-6.
22. 22. Chapman L, Hartley M, Khan A, et al. Changes in plasma HIV RNA after immune activation by vaccinations and acute illnesses [abstract 241]. In: Program and abstracts of the 2nd National Conference on Human Retroviruses and Related Infections (Washington, DC). Herndon, VA: American Society for Microbiology, 1995.
23. 23. U.S. Public Health Service. Prevention and control of influenza: part 1, vaccines. Recommendations of the Immunization Practices Advisory Committee (ACIP). MMWR Morb Mort Wkly Rep 1994;43(RR-9):5.
24. 24. Kendal AP, Skehel JJ, Periera MS. Concepts and procedures for laboratory-based influenza surveillance. Atlanta: Centers for Disease Control, 1982: 317-35.
25. + T lymphocytes in adults infected with human immunodeficiency virus. Clin Infect Dis 1995;21:1197-203.
26. 26. Kroon FP, van Dissel JT, Ravensbergen E, Nibbering PH, van Furth R. Antibody response to tetravalent pneumococcal conjugate vaccine in HIV-infected adults [abstract We.B.115]. In: Program and abstracts of the XI International Conference on AIDS (Vancouver, British Columbia, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
27. 27. Salassa B, Zucco S, Macor A, et al. Influenza vaccine response in HIV patients [abstract We.B.3371]. In: Program and abstracts of the XI International Conference on AIDS (Vancouver, British Columbia, Canada). Vancouver: XI International Conference on AIDS Society, 1996.
28. 28. Peters VB, Sood SK. Immunity to Haemophilus influenzae type b polysaccharide capsule after vaccination with the complete series of oligosaccharide CRM197 conjugate vaccine in infants with human immunodeficiency virus infection. J Pediatr 1996;128:363-5.
29. 29. Mellors JW, Kingsley LA, Rinaldo CR Jr, et al. Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med 1995;122:573-9.
30. 30. Mellors JW, Munoz A, Giorgi JV, et al. Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med 1997;126:946-54.
31. 31. Hammer SM, Squires KE, Hughes MD, Grimes JM, et al. A controlled trial of two nucleoside analogues plus indinavir in persons with human immunodeficiency virus infection and CD4 cell counts of 200 per cubic millimeter or less. N Engl J Med 1997;337:725-33.
32. 32. Cohen JP, Macauley C. Susceptibility to influenza A in HIV-positive patients. JAMA 1989;261:245.
33. 33. Safrin S, Rush JD, Mills J. Influenza in patients with human immunodeficiency virus infection. Chest 1990;98:33-7.
34. 34. Fine AD, Bridges C, Montepiedra A, et al. Should persons with HIV infection receive influenza vaccination? Observations from an outbreak of influenza A at a residential facility for persons with AIDS, New York City [abstract]. In: The 47th Annual Epidemic Intelligence Service Conference (Atlanta). Atlanta: Centers for Disease Control and Prevention, 1998.
35. 35. Glaser JB, Volpe S, Aguirre A, Simpkins H, Schiffman G. Zidovudine improves response to pneumococcal vaccine among persons with AIDS and AIDS-related complex. J Infect Dis 1991;164:761-4.